Oxbow Advisors’s Intuitive Surgical ISRG Stock Holding History

Oxbow Advisors’s Portfolio ISRG Stock Details ISRG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-720	Closed	-$221K	–	298
2021 Q2	$221K	Buy	+720	New	+$202K	0.02%	268

Other funds holding ISRG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Oxbow Advisors's ISRG Position: Q3 2021 in Review

Oxbow Advisors sold out of Intuitive Surgical (ISRG) in Q3 2021, closing a stake of 720 shares — an estimated $221K sold.

Oxbow Advisors first reported a position in ISRG in Q2 2021 and held it in 1 quarter. The position peaked at $221K in Q2 2021. 1,371 funds tracked by Wall St. Rank hold ISRG as of Q3 2021.

Oxbow Advisors reported no remaining Intuitive Surgical position as of Q3 2021 after selling out during the quarter.
Oxbow Advisors sold 720 Intuitive Surgical shares in Q3 2021, an estimated $221K.
Oxbow Advisors first reported a position in Intuitive Surgical in Q2 2021 and held it in 1 quarter.
Oxbow Advisors's Intuitive Surgical position peaked at $221K in Q2 2021.
1,371 funds tracked by Wall St. Rank held Intuitive Surgical as of Q3 2021.

Based on Oxbow Advisors's 13F filing for Q3 2021, filed 10 Nov 2021.